OpGen is a precision medicine company that develops molecular testing and bioinformatics to combat multi-drug resistant bacterial infections.Read more
OpGen's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 12.3M. Over the last two quarters, OpGen's revenue has decreased by 73.2%. Specifically, in Q2 2021's revenue was $ < 1M; in Q4 2020, it was $3M.